Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

LifeSignals

Explore full profile

Communications company with the domain knowledge essential to understanding the business needs & technical requirements

Fremont, United StatesFounded 2008Health Tech & Medtech
Valuation $25–50M Last recorded · 2016
Headcount 100–500 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for LifeSignals and the history behind them.

About LifeSignals

LifeSignals develops and manufactures a semiconductor platform designed for capturing and transmitting vital signs to the cloud. The company was co-founded by CEO Surendar Magar, a seasoned professional in the high-tech industry who previously co-invented Texas Instruments' groundbreaking TMS320 digital signal processing chip. His work in healthcare as an Executive-in-Residence at Mohr Davidow Ventures ultimately led to the creation of LifeSignals. Co-founder Ali Niknejad serves as the Chief Technologist.

Read full description

The company's core technology is the patented LifeSignals Processor, a low-cost, single-chip solution that serves as the foundation for its products. LifeSignals' business model revolves around providing this technology platform to partners, such as healthcare device OEMs and telehealth software providers, enabling them to develop and commercialize clinical-grade remote monitoring wearables. This strategy is supplemented by partnerships with manufacturing firms like STMicroelectronics and Dreamtech to ensure scalable, high-volume production.

LifeSignals offers an end-to-end ecosystem, the UbiqVue™ Wireless Patient Monitoring System, which includes single-use, wearable biosensors, a relay device, a secure cloud server, and commercial applications. These disposable, chest-worn biosensors can continuously collect physiological data for up to seven days. The captured data, including two-channel ECG, respiration rate, skin temperature, and motion, is transmitted wirelessly to a cloud server for analysis. Healthcare professionals can then access this near real-time data through a web portal, facilitating informed clinical decisions for patients in various settings, including hospitals, homes, and ambulatory care. The system has received multiple FDA 510(k) clearances, validating its use for both hospital and remote patient monitoring.

A key product is the UbiqVue 2A Multiparameter System, which has also secured FDA clearance. This system features a single-use biosensor that can continuously monitor SpO2 from the chest, along with twelve other parameters like pulse rate and body temperature. Another offering, the UbiqVue Holter System, is designed to accelerate cardiac monitoring by delivering diagnostic reports within hours of test completion, eliminating the need for patients to return the device. The company's technology is designed to be interoperable, allowing for straightforward integration into various health monitoring platforms and apps. Keywords: remote patient monitoring, wearable biosensors, clinical-grade wearables, physiological data, semiconductor platform, UbiqVue, wireless patient monitoring, single-use biosensor, telehealth technology, medical device OEM, cardiac monitoring, ECG patch, Holter monitoring, vital signs monitoring, population health management, hospital-at-home, cloud-based healthcare, Surendar Magar, medical IoT, digital health

Source: Dealroom company data

At a glance

Status
Operational
Founded
2008
Headquarters
Fremont, United States
Employees
97
Open positions
None listed
Dealroom signal
79.6/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Remote Monitoring, Biosensors, Spinout, Wearable, Tech for Medical Professionals, Tech for Patients, remote health monitoring, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
b2b
Investment activity
1 company, latest Jan 2020
Capital deployed
—
Preferred round
MERGER

Funding history

7 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
CONVERTIBLEOther financing May 2026 $4.5M — Ultragreen.ai ↗
MERGEROther financing Jan 2020 $0 — Renew Health ↗
Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

LifeSignals website traffic

Latest recorded traffic for LifeSignals is 3.5K monthly website visits, up 94.4% over the last three months. LifeSignals's team grew 12.8% over the past year.

Latest monthly visits3.5K 3-month web change+94.4% 1-year team growth+12.8%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Xseed Capital

Series A2 investors entered at this stage

  • Seraph Group
  • Ultragreen.ai

Other known investors3 additional known investors

  • Renew Health
  • University of California, Berkeley
  • Intuitive Private Equity
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
5 countries with
team presence
🇮🇳 India88.2%
🇺🇸 United States7.3%
🇳🇬 Nigeria1.5%
🇮🇪 Ireland1.5%
🇬🇧 United Kingdom1.5%
5 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about LifeSignals on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See LifeSignals’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.